MicroPhage, Inc., a platform diagnostic technology company, develops medical diagnostics for bacterial identification and antibiotic susceptibility/resistance testing. Its products include methicillin-susceptible Staphylococcus aureus (MSSA)/methicillin-resistant Staphylococcus aureus (MRSA) blood culture tests, MRSA screening tests, andMRSA/MSSA screening tests. The company was founded in 2002 and is based in Longmont, Colorado.

MicroPhage, Inc.

Org chart

Similar companies